Product Information
HYDROXYZINE HCL 25 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0342 per EA under NDC 16571011410. Its NADAC has been published 121 times since May 1, 2024.
FDA first approved this application on Aug 17, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571011410
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROXYZINE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA217652FDA Approved
8/17/2023
TE Code
AB
On Market Since
8/22/2023
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYZINE HCL 25 MG TABLET has been published 121 times since May 1, 2024, and over the history we have for it it has declined 4.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0342 per EA |
|---|---|
| All-time high | $0.0469 (Nov 13, 2024) |
| All-time low | $0.0341 (Nov 20, 2024) |
| 52-week high | $0.0377 |
| 52-week low | $0.0342 |
| Median price | $0.0368 |
| Average price | $0.0384 |
| Largest weekly change | -27.4% (Nov 20, 2024) |
| Weeks tracked | 121 |
| Tracking since | May 1, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROXYZINE HCL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE HCL 25 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0342 per EA (NDC 16571011410), effective Aug 19, 2026.
How has the price of HYDROXYZINE HCL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROXYZINE HCL 25 MG TABLET has declined 4.8%. It has been tracked across 121 weekly CMS publications since May 1, 2024.
What are the highest and lowest recorded NADAC prices for HYDROXYZINE HCL 25 MG TABLET?
Since May 1, 2024, the NADAC for HYDROXYZINE HCL 25 MG TABLET has ranged from a low of $0.0341 (Nov 20, 2024) to a high of $0.0469 (Nov 13, 2024), with a median of $0.0368 per EA.
Are there cheaper alternatives to HYDROXYZINE HCL 25 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as HYDROXYZINE HCL 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDROXYZINE HCL 25 MG TABLET?
HYDROXYZINE HCL 25 MG TABLET (NDC 16571011410) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.